HUP0203835A3 - Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as the active ingredient - Google Patents

Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as the active ingredient

Info

Publication number
HUP0203835A3
HUP0203835A3 HU0203835A HUP0203835A HUP0203835A3 HU P0203835 A3 HUP0203835 A3 HU P0203835A3 HU 0203835 A HU0203835 A HU 0203835A HU P0203835 A HUP0203835 A HU P0203835A HU P0203835 A3 HUP0203835 A3 HU P0203835A3
Authority
HU
Hungary
Prior art keywords
derivatives
preparing
active ingredient
same
drugs containing
Prior art date
Application number
HU0203835A
Other languages
English (en)
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of HUP0203835A2 publication Critical patent/HUP0203835A2/hu
Publication of HUP0203835A3 publication Critical patent/HUP0203835A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0203835A 1999-09-27 2000-09-26 Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as the active ingredient HUP0203835A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27184399 1999-09-27
PCT/JP2000/006601 WO2001023361A1 (fr) 1999-09-27 2000-09-26 Derives de la pyrimidine, leur procede de preparation, et medicaments les contenant comme principe actif

Publications (2)

Publication Number Publication Date
HUP0203835A2 HUP0203835A2 (en) 2003-05-28
HUP0203835A3 true HUP0203835A3 (en) 2003-07-28

Family

ID=17505658

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203835A HUP0203835A3 (en) 1999-09-27 2000-09-26 Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as the active ingredient

Country Status (12)

Country Link
EP (1) EP1219608A4 (hu)
KR (1) KR20020028232A (hu)
CN (1) CN1399632A (hu)
AU (1) AU7444600A (hu)
BR (1) BR0014319A (hu)
CA (1) CA2385292A1 (hu)
HU (1) HUP0203835A3 (hu)
MX (1) MXPA02003186A (hu)
NO (1) NO20021527L (hu)
NZ (1) NZ517962A (hu)
WO (1) WO2001023361A1 (hu)
ZA (1) ZA200202426B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002014310A1 (ja) * 2000-08-10 2004-01-15 小野薬品工業株式会社 ２−［５−アミノ−６−オキソ−２−フェニル−１，６−ジヒドロ−１−ピリミジル］−Ｎ−［１−（２−［５−ｔ−ブチル−１，３，４−オキサジアゾリル］カルボニル）−２−（Ｒ，Ｓ）−メチルプロピル］アセトアミド・塩酸塩化合物
CA2421499A1 (en) * 2000-09-08 2003-03-06 Ono Pharmaceutical Co., Ltd. Novel crystals of 1,3,4-oxadiazole derivative, process for producing the same and pharmaceutical agent containing the same as active ingredient
IL148924A (en) * 2002-03-26 2015-06-30 Mor Research Applic Ltd Use of substances that inhibit intracellular elastase activity in the preparation of a drug for the treatment and / or prevention of necrosis of cells and related diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216272D0 (en) * 1991-08-15 1992-09-09 Ici Plc Substituted heterocycles
HUP0100669A3 (en) * 1996-12-06 2001-12-28 Cortech Inc Denver Peptide derivatives as serine protease inhibitors, their use and pharmaceutical compositions comprising thereof
ZA9810490B (en) * 1997-12-03 1999-05-20 Dainippon Pharmaceutical Co 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor

Also Published As

Publication number Publication date
BR0014319A (pt) 2002-07-16
NO20021527L (no) 2002-05-27
MXPA02003186A (es) 2002-10-31
NO20021527D0 (no) 2002-03-26
WO2001023361A1 (fr) 2001-04-05
CN1399632A (zh) 2003-02-26
AU7444600A (en) 2001-04-30
NZ517962A (en) 2003-11-28
KR20020028232A (ko) 2002-04-16
CA2385292A1 (en) 2001-04-05
HUP0203835A2 (en) 2003-05-28
ZA200202426B (en) 2003-08-19
EP1219608A4 (en) 2003-01-08
EP1219608A1 (en) 2002-07-03

Similar Documents

Publication Publication Date Title
HUP0204170A3 (en) 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
HUP0201832A3 (en) Quinazoline derivatives, pharmaceutical compositions containing these compounds, and processes for preparing them
HUP0105114A3 (en) Quinazolinone derivatives, pharmaceutical compositions containing them, their use and process for their preparation
HUP0104964A3 (en) Quinazoline derivatives as angiogenesis inhibitors, process for their preparation and medicaments containing the compounds
AU7962200A (en) Novel indole derivatives and drugs containing the same as the active ingredient
HUP0105136A3 (en) Amide derivatives, process for their preparation and medicaments containing them
HUP0300618A3 (en) Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
IL148870A0 (en) 2'-substituted 1, 1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
HUP0203385A3 (en) Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0202075A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
ZA200109602B (en) Purine derivatives, preparation method and pharmaceutical compositions containing same.
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
AU6309698A (en) Drugs containing aminopyridine derivatives as the active ingredient
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
HUP0201315A3 (en) 4-phenyl-pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
HUP0201552A2 (en) Quaternary ammonium derivatives, method for preparing the same and their pharmaceutical use
HK1050003A1 (en) Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them.
HUP0201797A3 (en) 3-amino-2-benzyl-1-phenyl-propane derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0202832A3 (en) New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
HUP0200376A2 (en) Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use
HUP0203835A3 (en) Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as the active ingredient
HUP0203161A3 (en) Benzamidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use